A new pill for advanced prostate cancer after hormone therapy
Part of Cancer clinical trials.
This trial tests a new pill for advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The pill targets a specific gene change in the cancer, so part of the trial includes genetic testing of your tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that has spread beyond the prostate, confirmed by a biopsy or imaging.
- You are 18 years or older.
- You are generally able to carry out daily activities (ECOG score 0 or 1).
- Your cancer has gotten worse despite using at least one newer hormone therapy.
- You have had a recent blood test showing your blood counts, liver, and kidney function are within acceptable limits.
- You agree to provide a tumor sample for genetic testing to check your androgen receptor gene status.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two drugs for men with advanced prostate cancer that has stopped responding to hormone therapy. The drugs are cabozantinib (a pill that may slow cancer growth) and a radioactive therapy that targets prostate cancer cells (177Lu-PSMA-617). The goal is to see if this combination is safe and effective.
This study tests an experimental pill called TQB3217 for people with advanced solid tumors that haven't responded to usual treatments. The goal is to see if the pill is safe, how it works in the body, and whether it helps shrink or slow the cancer.
This trial tests a new drug called TQB3142 in people with advanced cancers that have not responded to standard treatments. The goal is to find a safe dose and see how the drug works in the body.
This trial tests two new drugs (QLC5508 and QLH12016) alone or together with other treatments for prostate cancer that has spread to other parts of the body. It may be an option if standard treatments have stopped working or caused side effects.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
This trial tests an experimental oral capsule (TQB3122) for safety and early signs of effectiveness in people with advanced solid tumors that have not responded to standard therapies. It is for patients who are relatively healthy and have specific cancer types like ovarian, breast, or prostate cancer.
Hear when a new Metastatic Castration-resistant Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.